Home > Insider Trading > Filing (0001181431-10-052250)

Filing Details

Accession Number:: 0001181431-10-052250
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-27 17:42:32
Reporting Period:: 2010-10-27

Filing Date:: 2010-10-27
Accepted Time:: 2010-10-27 17:42:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503685	Michele Ollier	C/O Index Ventures 2 Rue De Jargonnant Geneva V8 1207		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-27	1,367,346	$0.00	1,371,518	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2010-10-27	477,723	$0.00	1,849,241	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2010-10-27	881,128	$7.60	2,730,369	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2010-10-27	315,789	$9.50	3,046,158	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-10-27	3,533,095	$0.00	1,367,346	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-10-27	782,801	$0.00	477,723	$0.00
Common Stock	Senior Subordinated Convertible Promissory Notes	Acquisiton	2010-10-21	0	$0.00	881,128	$7.60
Common Stock	Senior Subordinated Convertible Promissory Notes	Disposition	2010-10-27	0	$0.00	881,128	$7.60

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Indirect
	No	4	C	Indirect
2011-12-31	No	4	A	Indirect
2011-12-31	No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,172	Indirect	See Footnotes

Footnotes

Michele Ollier, Director of the Issuer, is a partner of Index Ventures which is affiliated with Index Ventures III (Jersey), L.P. ("IVIII Jersey"), Index Ventures III (Delaware), L.P. ("IVIII Delaware"), Index Ventures Parallel Entrepreneur Fund (Jersey) ("IVPEF") and Yucca Partners L.P. (Jersey Branch) as Administrator of the Index Co-Investment Scheme ("Yucca"). Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein.
IVIII Jersey is the direct beneficial owner of 1,356 shares of common stock of the Issuer; IVIII Delaware is the direct beneficial owner of 2,754 shares of common stock of the Issuer; IVPEF is the direct beneficial owner of 48 shares of common stock of the Issuer; and Yucca is the direct beneficial owner of 14 shares of common stock of the Issuer.
Upon the closing of the Issuer's initial public offering on October 27, 2010, each share of Series A Convertible Preferred Stock (the "Series A Shares") and each share of Series B Convertible Preferred Stock (the "Series B Shares"), plus accrued dividends, immediately converted into shares of common stock of the Issuer in accordance with the terms of the Issuer's Third Amended and Restated Certificate of Incorporation. The Series A Shares converted on a 1-for-0.38701117412 basis and the Series B Shares converted on a 1-for-0.6102765793 basis. The Series A Shares and the Series B Shares were convertible at any time, at the holder's election, and automatically upon the consummation of the Issuer's initial public offering and had no expiration date.
IVIII Jersey is the direct beneficial owner of 444,181 shares of common stock issued upon the conversion of its Series A Shares and 153,242 shares of common stock issued upon the conversion of its Series B Shares; IVIII Delaware is the direct beneficial owner of 902,307 shares of common stock issued upon the conversion of its Series A Shares and 311,294 shares of common stock issued upon the conversion of its Series B Shares; IVPEF is the direct beneficial owner of 16,073 shares of common stock issued upon the conversion of its Series A Shares and 5,544 shares of common stock issued upon the conversion of its Series B Shares; and Yucca is the direct beneficial owner of 4,785 shares of common stock issued upon the conversion of its Series A Shares and 7,643 shares of common stock issued upon the conversion of its Series B Shares.
The outstanding principal and accrued and unpaid interest on these senior subordinated convertible promissory notes (the "Convertible Notes")automatically converted into shares of common stock upon the closing of the Issuer's initial public offering, at $7.60 per share, 80% of the Issuer's initial public offering price per share.
IVIII Jersey is the direct beneficial owner of 285,307 shares of common stock issued upon the conversion of its Convertible Notes; IVIII Delaware is the direct beneficial owner of 579,571 shares of common stock issued upon the conversion of its Convertible Notes; IVPEF is the direct beneficial owner of 10,320 shares of common stock issued upon the conversion of its Convertible Notes; and Yucca is the direct beneficial owner of 5,930 shares of common stock issued upon the conversion of its Convertible Notes.
Shares acquired upon the closing of the Issuer's initial public offering at the initial public offering price of $9.50 per share.
IVIII Jersey acquired Convertible Notes with a face amouont, including principal and accrued interest, of $2,168,344.80; IVIII Delaware acquired Convertible Notes with a face amount, including principal and accrued interest, of $4,404,755.93; IVPEF acquired Convertible Notes with a face amount, including principal and accrued interest, of $78,461.47; and Yucca acquired Convertible Notes with a face amount, including principal and accrued interest, of $45,110.17.
IVIII Delaware is the direct beneficial owner of 315,789 shares of common stock of the Issuer.